COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk files annual report with the SEC
08/02/2018
Bagsværd, Denmark, 8 February 2018 - Novo Nordisk A/S has filed its Annual Report 2017 on Form 20-F for the financial year 2017 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of [...]
HempTech (HTCO), a Nuvus Company, Rolls Out Grow.Droid Enterprise Station – Expandable to Thousands of Plants – Perpetual Harvest Starting in 8 to 10 Weeks
08/02/2018
Saint Petersburg, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- HempTech Corp. (OTC PINK: HTCO), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]
Abattis Completes Investment in CannaNUMUS Blockchain and Announces CannaNUMUS’s Achievement of a Significant Milestone
08/02/2018
VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) announces that, further to its news release dated February 1, 2018, it has [...]
Ultragenyx to Present at Leerink Partners Global Healthcare Conference
08/02/2018
NOVATO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
First Choice Healthcare Solutions’ Wholly-Owned Subsidiary Acquires Majority Ownership Interest in Crane Creek Surgery Center
08/02/2018
Management to Host Shareholder Update Conference Call to Discuss Crane Creek and Strategic Partnership in Further Detail on Thursday, February 8th at 11:00 a.m. ET MELBOURNE, Fla., Feb. 08, 2018 (GLOBE NEWSWIRE) -- [...]
Arbutus Consolidates HBV Business Around Warminster, PA Site
08/02/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]
Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Humphrey’s 4th Annual Orphan Drug Day
08/02/2018
HAYWARD, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening [...]
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Developments on March 1, 2018
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Tower One Continues to Build and Receive Additional Search Rings
08/02/2018
VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces that tower demand in Argentina has remained [...]
Cellectar Biosciences to Present at the 2018 BIO CEO & Investor Conference
08/02/2018
MADISON, Wis., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Momenta Pharmaceuticals to Webcast Presentation at the LEERINK Partners 7th Annual Global Healthcare Conference
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]
Genocea to Host Fourth Quarter and Year End 2017 Financial Results Conference Call & Webcast on February 15, 2018 at 9 a.m. ET
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]
Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
Opiant Pharmaceuticals to Record Approximately $11.7 Million in Royalty and Milestone Payments Related to 2017 Sales of NARCAN® Nasal Spray for Opioid Overdose
08/02/2018
SANTA MONICA, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced [...]
Provant Health to Provide Biometric Screenings at American Heart Association’s Go Red for Women Event
08/02/2018
OLATHE, Kan., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. d/b/a Provant Health (OTCQX:HPHW), the largest publicly traded, pure-play well-being leader in workplace population health and clinical research [...]
Alder BioPharmaceuticals® to Present at Two Upcoming February Investor Conferences
08/02/2018
BOTHELL, Wash., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma
08/02/2018
Haichang to fund development through completion of Phase IIa Proof-of-Concept Clinical Trial Clinical trials will be designed to meet both the US and China FDA requirements ROCKVILLE, Md., Feb. 08, 2018 (GLOBE NEWSWIRE [...]
Radius Health to Present at Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
WALTHAM, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative [...]
Emerald Health Therapeutics Announces $18 Million Prospectus Sale; Concurrent Secondary Sale
08/02/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) ("Emerald" [...]

Pages